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ABSTRACT The aim of this study was to analyze the effects on blood sugar concentrations through the calculation of the
glycemic score (GS) of 10 different high-protein low-carbohydrates (CHOs) proprietary foods that are commonly used as meals
during very low-CHO ketogenic diets or during low-CHO diets. Fourteen healthy females were tested for their glycemic
response curve elicited by 1000 kJ of glucose three times within a 3-week period (one test each week) compared with one of 10
test foods once on separate days twice a week. After determining the GS of each food in each individual, the mean GS of each test
food was calculated. All test foods, compared with glucose, produced a significantly lower glycemic response. The GS of all test
food resulted in being lower than 25 and the difference between the mean glycemia after the intake of glucose (mean 122 – 15 mg/
dL) and after the intake of the sweet test foods (mean 89– 7 mg/dL) was 33 mg/dL (P< .001), whereas the difference between the
mean glycemia after the intake of glucose and after the intake of savory test foods (mean 91– 8 mg/dL) was of 31 mg/dL
(P < .001). Conclusions: The reformulation of ultraprocessed ready-to-consume foods in a low-CHO, high-protein version can
produce a significantly lower glycemic response whilst maintaining the valued ready-to-use format and high palatability
demanded by consumers. The low impact on postprandial glycemia and the nutritional characteristics of these proprietary foods
makes them useful in both weight control management strategies and in the care management of diabetes.
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INTRODUCTION
Despite being considered a ‘‘preventable disease’’ bythe World Health Organization, obesity is rising in both
high-income and low-income countries.1 Moreover, over-
weightness and obesity are one of the major causes of the
worldwide burden of the four main noncommunicable dis-
eases: cardiovascular (CV) diseases, chronic respiratory
diseases, cancers, and diabetes mellitus (DM).2
Among multiple reasons involved in the onset of over-
weight and obesity, nutrition appears to be the most impor-
tant one.3 However, research has yet to produce a generally
accepted nutritional approach.4 Populations experiencing an
increase in obesity and CV diseases show common eating
and drinking habits, notably a general decrease in intake of
minimally processed foods and in an increase in the con-
sumption of ultraprocessed ready-to-consume products.
These foods, based on the accepted definition acknowledged
by the Pan American Health Organization,5 are ‘‘industrial
formulations manufactured from substances derived from
foods or synthesized from other organic sources. (.) Most
of these products contain little or no whole food. They are
ready-to-consume or ready-to heat, and thus require little or
no culinary preparation.’’ Examples of ultraprocessed foods
are savory and sweet snacks, ice cream, frozen and chilled
ready meals, and soft drinks,5 and they seem to be the cause
of the extra daily diet calorie intake of both the young and the
older populations.6 Ultraprocessed ready-to-consume prod-
ucts present particular characteristics, which make them
extremely profitable for producers and retailers and highly
attractive for consumers. For example, consumers purchase
them because they commonly require a minimal culinary
action, they are flavorsome, and are relatively inexpensive.
However, when analyzing ultraprocessed products, less
protein, potassium, and dietary fiber and more free sugar,
total saturated and transunsaturated fats, and sodium are
generally evident when compared with traditional foods.7,8
All these characteristics appear to be linked to the burden
of obesity and metabolic syndrome (MetS).6 A potential
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solution to this scenario could be to review ultraprocessed,
ready-to-consume products by reduction of their sugar and
fat contents. A particular kind of these new ultraprocessed
ready-to-consume products are proprietary foods that are
high in proteins and fibers and low in sugar and saturated
fats. These are specifically designed for particular diets such
as the ketogenic regimen, but are also successfully used in
more easy low-carbohydrate (CHO) diets as snacks or meal
replacements.9 During ketosis, CHO intake must be under
30 g/day,10,11 and in previous studies,4,9 we demonstrated
that these special foods, which mimic the taste and aspect of
high-content CHO foods but are low in sugar and high in
protein content, were able to increase the compliance of
subjects to the ketogenic diet. Moreover, after the termina-
tion of a very low-CHO ketogenic diet (VLCKD) inter-
vention, patients tended to maintain the consumption of
those proprietary foods during the day (usually at breakfast
or during breaks). This can be considered a positive change
of behavior, because it is known that meal replacement
during the maintenance phase is useful to prevent weight
gain.12 During consumption of a VLCKD, it is mandatory
to maintain a low level of glycemia (about 80–90 mg/dL) to
avoid insulin spikes.13 This condition allows subjects to
improve their fat oxidation as demonstrated by Paoli et al.14
and by Tagliabue et al.15
Another important aspect of a VLCKD is the influence of
such dietary regimen on the perception of hunger.16 It has
been suggested that ketone bodies reduce hunger through
different and complex mechanisms17; in contrast it is known
that postprandial glucose and insulin spikes, typically pro-
duced after the intake of traditional ultraprocessed products
that usually show a high glycemic index (GI),5 elicit food
craving and overeating, with a preference for high-GI
CHOs,18 a phenomenon defined as the CHO-craving ef-
fect.19 Conversely, the consumption of nonprocessed foods
low in simple sugars may ameliorate overeating and facili-
tate the maintenance of a healthy weight.18
The mentioned positive changes necessitate the need to
analyze the effect of different high-protein low-CHO pro-
prietary foods that are commonly used in diets, i.e. during
VLCKD and low-CHO diets (LCD), on glycemia compared
with glucose.
MATERIALS AND METHODS
Subjects were recruited through advertisement placed in
two pharmacies located in the province of Vicenza (Veneto,
Italy). Exclusion criteria for this study were the presence of
diabetes or prediabetes, being on a food diet, and females
who were either pregnant or breast feeding. After a prese-
lection process of 32 participants, 14 females were eligible
to participate in this study (mean age: 42– 13, mean weight:
72– 21 kg, mean BMI: 26– 7). Participants were required to
report any change of daily habits, such as engaging in a new
exercise program, new pharmaceutical interventions, or
engaging in other than the present diets during the experi-
mental phase, which would have resulted in the exclusion
from the study. The study was approved by the Ethical
Board of the University of Padova, Department of Biome-
dical Sciences, and conformed to standards for the use of
human subjects in research as outlined in the Declaration of
Helsinki. Investigators explained the purpose of the study,
the protocol to be followed, and the experimental proce-
dures to be used before the start of the study. Subjects were
required to sign a participation consent form and they did
not receive any monetary compensation.
Subjects were tested for individual glycemic response
curves elicited by the ingestion of 1000 kJ of glucose three
times within a 3-week period (one test per week) and that of
each of 10 high-protein low-CHO proprietary test foods once
on separate days twice a week (Fig. 1). Tests were performed
in the morning after 10–12 h overnight fast. Subjects were
asked to have a regular meal, not to consume any alcohol, and
to avoid any unaccustomed exercise the night before tests.
During the study period, participants maintained a constant
foods supply, without changing their usual eating habits.
Fingertip capillary blood samples were collected in the
fasted state and after 15, 30, 45, 60, 90, and 120 min after
starting to eat, changing the finger each time to avoid trau-
matization of the skin. The puncture was performed with the
lancet Accu-Check Safe-T-Pro Plus (Roche Diagnostics,
Basel, Switzerland) and blood was collected directly and im-
mediately analyzed using test strip Reflotron Glucose.20–22
Postprandial effect of sugar content on glycemia is commonly
defined through three methods: the GI, the glycemic load
(GL), and the glycemic score (GS).
The GI method was developed to rank foods according to
the extent to which they increase blood sugar concentra-
tions23 and it is a number that ranges from 0 to 100, where
100 represents the GI of the reference food glucose. To
calculate the GI of a particular food, the area under the curve
(AUC) of the rise in blood sugar for a 2 h postprandial period
is calculated. This value is consequently expressed as a
percentage of the incremental AUC after the consumption of
a reference food (commonly white bread or glucose) con-
sumed by the same person on a different day.24
The test food and the reference food must contain the
same amount of available CHO (25 or 50 g) and the indi-
vidual has to perform the test under standardized conditions.
The GL method takes into account not only the magnitude
of the glucose blood spike but also the content (grams) of
CHO in the portion of food consumed, and it is calculated as
the mathematical product of the GI for the available CHO
content of the food.25
GI¼ 120min iAUC(blood sugar) for portion size of test foods containing 50g (or 25g) of available carbohydrate
120miniAUC blood sugarð Þfor portion size of reference food containing 50g (or 25g) of available carbohydrate · 100
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The GS method tests the glycemic response after
the ingestion of low-CHO foods and differs from the GI
as it does not compare a standard amount of available
CHO.
However, it compares the effect on glycemia of a 1000 kJ
portion of both test food and reference food.25
Due to the very low-CHO content of the tested foods and
because of the quantity of food required to reach the 25 g of
available CHO for the calculation of GI being too large, this
study utilized the GS method.25
Each tested food was served as a 1000 kJ portion with
220 mL warm (no sugar) tea for a better compliance of
subjects in cold winter mornings after an overnight fast (tea
does not alter the incremental area under the glycemic re-
sponse curve26) and consumed within a period of 10 min.
This study tested 10 proprietary foods selected from the
product range of Tisanoreica snacks and meals (Gianluca
Mech S.p.A., Asigliano Veneto, Vicenza, Italy). These are
ready-to-consume foods high in protein and fiber content
and low in CHO content designed to be consumed during a
VLCKD or an LCD regimen.4,9,27
Among the products selected, six of them were sweet
(chocolate biscuits [CB; Cioco-Mech], chocolate and ha-
zelnut balls [CHB; Bon Mech], apple–cinnamon biscuits
[ACB; T-Biscuit], chocolate–almonds–pistachio bar [CAPB;
T-Smart], nuts and chocolate muffin [NCM; T-Muffin], and
chocolate drink [CD; Cocoa Drink]). The other four products
tested were savory (two different types of pasta P1 [Original
Tisanopast] and P2 [Tisanopast Style], the rosemary bread-
sticks [RB; T-Smech], and the pizza dough [PD; Pizza
Dough]) (Table 1). Glucose was used as reference food. This
was dissolved in 220 mL of water and served as 1000 kJ
portions (15.68 kJ/g)28 and had to be consumed within a
10 min period.
All statistical analyses were performed using package
GraphPad Prism version 6.00 for Mac, GraphPad Software
(San Diego, CA, USA). The AUC values above the fasting
glucose concentration for each test food and for the refer-
ence food were used to calculate the GS of each test food
and assessed using an XY data table by selecting the AUC
analysis. The effect of each test food on glycemia compared
with that of the reference food over time was assessed using
a mixed model ANOVA (time · treatment). A post hoc Si-
dak’s multiple comparison test was performed.
To select those test foods with a significant difference of
blood sugar values compared with the other test foods, a
two-way repeated measure ANOVA (time vs. nominal
variables test foods vs. measures) was performed. Each row
represented a different time point, so matched values were
stocked into a subcolumn. Tukey’s multiple comparison test
was chosen to compare columns within each row.
A bivariate analysis was used to test, through a linear
regression analysis, the significance of the associations be-
tween GS and sugars, and protein and fiber in the 10 foods
tested. An alpha level of P < .05 was used to denote a sig-
nificant effect.
RESULTS
Mean GS, mean glycemia, and mean glycemia in the
different time points of the 10 test foods and the reference
food among the subjects tested are listed in Table 2.
Table 1. Test Foods Characteristics
Test food
name kJ/100 g Protein/100 g, g
CHO/100 g (of which sugars/
of which polyalcohols), g
Fat/100 g (of which
saturated), g Fiber/100 g, g Salt/100 g
CB 1666.35 kJ/100 g 23.5 18 (0.1/14.5) 25.3 (11.2) 37.1 —
PD 1356 kJ/100 g 53.2 14.2 (1.6) 2.4 (0.9) 16.4 887 mg
CAPB 1498.87 kJ/100 g 34 10.9 (4/4.3) 14.4 (7.5) 28 1.13 g
NCM 1570 kJ/100 g 15.5 35.3 (0.1/30.1) 22.6 (5.5) 7.4 1.3 g
CD 1515.62 kJ/100 g 62.2 18.2 (0.4) 3.4 9.8 —
CHB 1775.2 kJ/100 g 6.1 51.6 (30.1/18.9) 28.2 (12) 7.6 0.02 g
RB 1900 kJ/100 g 49.10 8.96 (0.06) 21.06 (6.07) 16.12 0.80 g
ACB 1678 kJ/100 g 31.36 5.88 (0.06) 21.32 (12.42) 30.13 0.55 g
P1 962 kJ/100 g 44 5.9 (0.03) 3.3 34 720 mg
P2 1389 kJ/100 g 50 22.5 (0.7) 2.1 (1.6) 12.9 0.05 g
ACB, apple and cinnamon biscuits; CAPB, chocolate–almonds–pistachio bar; CB, chocolate biscuits; CD, chocolate drink; CHB, chocolate and hazelnut balls;
CHO, carbohydrate; NCM, nuts and chocolate muffin; P1, pasta type 1; P2, pasta type 2; PD, pizza dough; RB, rosemary breadsticks.
GL¼ GI test foodð Þ X available grams of CHO in the quantity of test food consumed
100
GS¼ 120 min iAUC blood sugarð Þ for 1000 kJ test food
120min iAUC blood sugarð Þfor 1000 kJ reference glucose · 100
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FIG. 1. Experimental design.
FIG. 2. Comparison of mean blood sugar concentrations between glucose and sweet test foods (*P< .05; **P< .01; ***P< .001; ****P< .0001). Foods
were tested among 14 healthy subjects. All tested foods and the reference food glucose were served as a 1000 kJ portion and consumed within 10 min.
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Mean glycemia after taking the reference food glucose
resulted in 122– 15 mg/dL, that after taking the sweet test
foods was 89– 7 mg/dL, and that after ingestion of the sa-
vory test foods was 91– 8 mg/dL.
Figure 2 shows the comparison of mean blood sugar
concentrations at the different time points between glucose
and sweet test foods, whereas Figure 3 shows that between
glucose and savory test foods. After the ingestion of all sweet
and savory test foods, the blood sugar showed always a sig-
nificantly lower trend compared with that after the intake of the
reference food glucose after 15, 30, 45, 60, and 90 min, al-
though several test foods (CHB, CAPB, NCM, ACB, PD, and
RB) were able to maintain this significance even after 120 min.
Figure 4 shows the comparison of blood sugar con-
centrations between sweet test foods and savory test foods.
Comparison of mean blood sugar concentrations at the seven
different time points highlighted a significant higher increase
of glycemia, particularly 15 and 30 min after taking the CHB
and the two kinds of pasta P1 and P2 compared with the other
test foods (Fig. 4).
In particular, the mean glycemia increased significantly
15 and 30 min after the intake of CHB compared with the
mean glycemia after the ingestion of the CB, the CAPB, the
RB, and the PD (Fig. 5).
After the intake of P2, the mean glycemia increased
significantly after 15 and 30 min. compared with the sweet
test foods CB, CAPB, and NCM and with the savory test
foods PD and SB (Fig. 6).
After the intake of P1, the mean glycemia increased
significantly after 15 and 30 min. compared with the sweet
test foods CB and CAPB and with the savory test foods PD
and RB (Fig. 7).
FIG. 3. Comparison of blood sugar concentrations between glucose and savory test foods (*P< .05; **P < .01; ****P < .0001). Foods were
tested among 14 healthy subjects. All tested foods and the reference food glucose were served as a 1000 kJ portion and consumed within 10 min.
FIG. 4. Comparison of blood sugar con-
centrations between sweet test foods and sa-
vory test foods. Among sweet test foods, the
CHB show a higher increase in blood sugar
than other test foods (significant differences
are shown in Fig. 5). Among savory test
foods, both pasta type 2 (P2) and pasta type 1
(P1) show a higher blood sugar trend (sig-
nificant differences are shown in Figs. 6 and
7). CHB, chocolate and hazelnut balls.
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The statistical two-way ANOVA of the trend of blood
sugar from before starting to eat up to 2 h after the intake of
the reference food or of the test foods shows that, on aver-
age, the 40% of the total variation observed is because of the
difference between the foods eaten (glucose or test foods).
This result shows that, among all the ‘‘Sources of Varia-
tion’’ analyzed (time, food, and subjects), the variable
‘‘food’’ appears to be the one that explains most of the
variation observed between the blood sugar trends after the
intake of test foods and the blood sugar trend after the intake
of the reference food.
The results did not show any correlation between GS and
fiber content (r =-0.08; P = .37), neither between GS and
sugar content (r = 0.17; P = .09), nor between GS and protein
content (Fig. 8).
The average GS of each test food, calculated as the mean
of GS values of each test food resulted from every subject,
was always less than 25 compared with the GS reference
value of glucose, which is 100 (Table 2). The test food with
the highest GS is the sweet test food Bon Mech with a GS of
23. The test food with the lowest GS is the sweet test food
Cioco Mech and T-Smart, with a GS of 14.
DISCUSSION
In this study, the GS of 10 proprietary foods high in
proteins and fibers and low in sugars and saturated fats was
tested. These proprietary foods claim to replicate the taste
and aspect of high-CHO foods and are commonly used as
meals during VLCKD regimens. In our study, the products
tested showed a significant lower blood sugar response and
lower GS than an isoenergetic amount of glucose. Among
the six sweet and four savory test foods, the CHB showed
the highest GS (GS = 23). This result is consistent with the
higher quantity of available sugars of CHB compared with
the other test foods. The CB and the CAPB had the lowest
GS of 14. This GS value is, according to the data avail-
able,25 similar to the GS value of a low-fat processed
cheese.
The macronutrient composition is important for glucose
response, with CHO as the food component that acts directly
on glycemia, rising it and stimulating insulin secretion.
However, even if CHO counting is still the basis for insulin
dose adjustment in diabetes care management,29 data show25
that sugar content could be a stronger predictor of the ob-
served glucose response than CHO. Other studies show that
the structure of CHOs should also be kept under consider-
ation: a disrupted structure, typical of processed whole
grains, has a different effect on glycemia compared with
intact grains.30
Even if there is a strong evidence supporting fibers’
beneficial effect in reducing disease risk,25 only soluble fi-
bers with gel-forming properties show a distinguishable
effect for glycemic control.31,32
This study does not show any significant relationship
between GS and fiber content, but, differently from them, it
does not show any correlations between GS and sugar
content (Fig. 8). This conflicting result might be because of
the very low quantity of available sugars in the test foods.
Finally, protein content, despite being considered predictive
for the GS,25 did not show such correlation in this study.
The low postprandial glycemia produced by the pro-
prietary foods tested is an important factor, because ultra-
processed ready-to-consume products are commonly high in
FIG. 5. Comparison of mean blood sugar
concentrations between the CHB and the
other test foods. Results show significant
differences after 15 or 30 min between CHB
and CB, RB, PD, and CAPB. *P < .05;
**P< .01; ***P < .001. CAPB, chocolate–
almonds–pistachio bar; CB, chocolate biscuits;
PD, pizza dough; RB, rosemary breadsticks.
FIG. 6. Comparison of mean blood sugar
concentrations between pasta type 2 (P2) and
the other test foods. Results show significant
differences after 15 or 30 min between P2
and CB, CAPB, PD, NCM, and RB. *P < .05;
**P< .01; ****P< .0001. NCM, nuts and choc-
olate muffin.
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simple sugars that negatively affect a number of health pa-
rameters. Postprandial hyperglycemia and compensatory
hypoglycemia are factors linked to the development of di-
abetes and CV diseases.33 Furthermore, the consumption of
high-sugar snacks seems to be the main cause for the in-
crease in intrahepatic triglyceride content.34 Finally, the
usual rapid and high glycemic peak caused by ultra-
processed products, together with their lack in fiber, pro-
teins, and water, triggers an excessive consumption.19,35
Sugar is rapidly absorbed and produces a consequent high
blood sugar spike that acts centrally, increasing the pro-
duction and utilization of dopamine, which imitates the
typical neuromodulation of addictive substances.36
The abuse of high sugary ultraprocessed foods leads to the
synthesis and the accumulation of fat and results in weight
gain,8 which increases the risk of obesity and MetS. Ac-
cording to the definition by the World Health Organization,
MetS is the simultaneous presence of insulin resistance
along with two other risk factors from high blood pressure,
raised triglycerides, low HDL, and increased BMI (or in-
creased waist:hip ratio) and microalbuminuria.37 The prev-
alence of this disease, once suggested to be exclusive of
adulthood, is becoming a major worldwide concern among
both children and adolescents,38,39 and the consumption of
ultraprocessed foods is considered an important risk factor
for its development.40 Bielemann et al.41 recently demon-
strated that ultraprocessed foods were responsible for 50%
of the daily caloric intake among a cohort of 23-year-old
participants in Brazil. Interestingly, the household avail-
ability of ultraprocessed ready-to-eat foods was associated
with a low percentage of proteins and fibers intake.
Appetite control is related not only to glucose content and
postprandial glycemia but also to other factors42 among
which the reward system in the brain, aside from the ho-
meostatic control by the hypothalamus, has been the focus
of recent interest, since food reward is a goal that drives both
appetite and eating.43,44
The larger the portion size, the more food is eaten,44 but
eating is only indirectly related to energy balancing because
it seems that we eat essentially for pleasure.44 These new
low-calorie proprietary foods could help to reduce energy
intake, useful for a better weight maintenance or a more
successful weight loss. Moreover, since high-energy-dense
foods have the lowest satiating capacity even if they usually
have a high palatability,44 the high level of proteins and
fibers and the high palatability, despite the low sugar con-
tent, of these new ultraprocessed foods, are important fea-
tures that contribute to both food reward and satiety.45
The tendency to prefer sugary fatty foods over savory
foods is considered innate and universal and finds its roots in
very important adaptive processes: a bitter taste is consid-
ered predictive of toxicity and then avoided (alkaloids,
glycosides, and other toxins have a bitter taste), whereas
sweet taste is associated with energy and nourishment.46
FIG. 7. Comparison of mean blood sugar
concentrations between the pasta type 1 (P1)
and the other test foods. Results show sig-
nificant differences after 15 or 30 min be-
tween P1 and CB, CAPB, PD, and RB.
*P< .05; **P< .01; ***P< .001; ****P< .0001.
FIG. 8. Bivariate correlations between observed glucose responses (GS) (relative to 1000 kJ glucose = 100), the available sugars, protein, and
fiber contents of the 10 single test foods. Linear regression analysis was used to test the significance of the associations. Each point on the graph
represents the mean result for each test meal (14 subjects). (A) Sugars—GS linear regression; (B) protein—GS linear regression; (C) fiber—GS
linear regression. GS, glycemic score.
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Although it is recognized that the VLCKDs lead to greater
weight losses than a low-calorie balanced diet at least in the
short term,47 subjects with a sweet food preference may not
adhere to this diet because of the lack of their preferred
taste.48,49 A VLCKD that includes these proprietary foods
that imitate taste and aspects of high-CHO food but have a
low glucose content can consequently produce a higher level
of adherence and a reduced drop-out rate.4,50
Sweet foods are usually rich in refined CHO, have a high
GI, and are related to an increased risk of overweight, obe-
sity,51 and type 2 diabetes mellitus (T2DM).52 T2DM is in-
creasing among young people53 and a dietary management is
the most important factor to be considered to prevent the
progression of impaired glucose tolerance to clinical DM. A
dietary management is also important to minimize the gly-
cemic variability, which is the measure of blood sugar con-
centration changes over time.54 An uncontrolled blood sugar
concentration is the major risk factor in the development of
T2DM complications such as retinopathy, neuropathy, ne-
phropathy, and CV diseases.55–58 It is important to make
healthier nutritional choices to prevent these complications,
which are associated with high economic, social, and per-
sonal costs. Low-CHO high-protein diets help to normalize
glycemic fluctuations in T2DM management.59 As sug-
gested by the European Association for the Study of Diabetes
(EASD), dietary fibers can further positively influence blood
sugar variability. The EASD consequently recommends the
consumption of high-fiber, low-GI foods as CHO source.54
Dietary amino acids contribute to the de novo synthesis of
glucose through gluconeogenesis and participate in the re-
cycling of glucose carbon through the glucose–alanine cy-
cle.60 However, dietary proteins have a minimal impact on
glycemia and insulin secretion compared with CHOs,61 and a
high-quality protein supplementation has been suggested
during weight loss programs to preserve muscle mass, to im-
prove glycemic regulation, and to maintain euglycemia.62,63
The 10 proprietary foods tested in this study are formulated
with whey proteins. These, because of their high content of
leucine, which promotes muscle mass synthesis and because
of their fast digestion and delivery of amino acids in the cir-
culation, are consequently considered the best type of pro-
teins.62
Moreover, whey protein decreases appetite better than
other types of proteins64 and increases satiety through an
increase of the release of CCK and GLP-1 and a reduction of
ghrelin levels.65
The sweet proprietary foods tested in this study also
contained low-calorie sweeteners. These are compounds
able to stimulate, in the same way as sugar does, the sweet
taste receptors.66
Unlike sugar, low-calorie sweeteners do not release energy
and hence they are used in weight loss programs even though
perceived as controversial by the scientific community. This
is due to low-calorie sweeteners producing possible adverse
metabolic effects, such as increase of appetite, weight gain,
and metabolic disorders.67–69 However, more studies are re-
quired to confirm these negative suggestions, since a recent
review shows that there is no evidence for a limitation of their
use to reduce energy intake.70 The same author states that our
congenitally liking for sweetness implies that the reward
value from sugar and low-calorie sweeteners is the same, but
low-calorie sweeteners should be preferred, because they
avoid the high-calorie intake side effect of sugar.44 These
compounds could be useful in the prevention of over-
weightness and obesity in populations that are less sensitive
to sweetness, predisposing them to consume more sugar to
have the same ‘‘taste sensation’’ as people more sensitive to
sweetness.71 Nowadays low-calorie sweeteners are impor-
tant tools in DM management, in which dietary adherence is
among the most difficult cornerstones,72 especially for chil-
dren and adolescents with T2DM who suffer from the per-
ceived lack of normality in their diet and consequently desire
nonrecommended sweet foods.73
Ready-to-consume proprietary foods, high in quality
proteins and fibers, could improve both the diet of young
people and the diet of T2DM patients. In the former popu-
lation, this could prevent them from eating high-sugary fatty
foods, predisposing them to the development of T2DM, and
in the latter to minimize blood sugar variability that often
complicates the pathology. The 10 proprietary foods tested
showed a significant lower glycemia than the standard food
glucose and their GS resulted in always lower than 25. This
low glycemic response, together with their valuable ready-
to-use format, makes these proprietary foods a valid tool
during both weight management and weight loss programs,
facilitating the adherence to an LCD of individuals who tend
to have a high preference for sweet foods.
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